-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TAK-186 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TAK-186 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TAK-186 in Pancreatic Cancer Drug Details: TAK-186 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TAK-280 in Metastatic Uveal Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TAK-280 in Metastatic Uveal Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TAK-280 in Metastatic Uveal Melanoma Drug Details: TAK-280 (MVC-280) is...
-
Product Insights
NewQuarterly Beer & Ale pricing trends in the United Kingdom
Empower your strategies with our Quarterly Beer & Ale pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TAK-186 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TAK-186 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TAK-186 in Non-Small Cell Lung Cancer Drug Details: TAK-186 is...
-
Product Insights
Cobra No 1 Mine
The Cobra No 1 Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our Cobra No 1 Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TAK-280 in Metastatic Uveal Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TAK-280 in Metastatic Uveal Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TAK-280 in Metastatic Uveal Melanoma Drug Details: TAK-280 (MVC-280) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TAK-280 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TAK-280 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TAK-280 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:...
-
Product Insights
Cobra Galisteo Solar PV Park
Cobra Galisteo Solar PV Park is a solar PV project located in Extremadura, Spain. The project is owned by Actividades de Construccion y Servicios SA; Galp Energia Espana SA and is developed by Actividades de Construccion y Servicios SA; Cobra Concesiones SL; Galp Energia Espana SA; Ignis Energia SL. The project is currently under construction. Empower your strategies with our Cobra Galisteo Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will...
-
Product Insights
Cobra Requena Solar PV Park 6
Cobra Requena Solar PV Park 6 is a solar PV project located in Valencian Community, Spain. The project is owned and being developed by Cobra Gestion De Infraestructuras SLU. The project is at the permitting stage. Empower your strategies with our Cobra Requena Solar PV Park 6 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...